ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings
  • Abstract Number: 1972 • 2017 ACR/ARHP Annual Meeting

    Causes of Death in 350 Patients with Systemic Autoimmune Rheumatic Diseases

    Juan Gabriel Ovalles-Bonilla1,2, Olaia Fernández-Berrizbeitia3, Julia Martínez-Barrio1, Larissa Valor1, Diana Hernández1, Iustina Janta1, Belen Serrano1, Claudia Saez1, Roberto Gonzalez1, María Correyero1, Leticia García1, Ana López-Cerón1, Alicia Silva1, Juan Carlos Nieto1, Carlos González1,4, Indalecio Monteagudo1 and Francisco Javier López Longo1,4, 1Rheumatology, Hospital General Universitario Gregorio Marañón, Madrid, Spain, 2Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain, 3Rheumatology, Hospital Universitario Basurto, Bilbao, Spain, 4Facultad de Medicina, Universidad Complutense de Madrid, Madrid, Spain

    Background/Purpose: The major SARD have an increased mortality compared to the general population. It is well known that the main causes of death in Systemic…
  • Abstract Number: 1973 • 2017 ACR/ARHP Annual Meeting

    Fibromyalgia in Real Life a National French Web-Based Survey in 4516 Patients

    Francoise Laroche1, julien Guerin2, deborah Azoulay3, joel Coste4 and serge Perrot3, 1Pain and Palliative care, APHP Hospital, Paris, France, 2CETD, APHP Hospital, Paris, France, 3CETD, Paris, France, 4Biostatistics in university Hospital, Paris, France

    Background/Purpose: Fibromyalgia (FM) is the most frequent widespread chronic pain disorder (1,6% of the French population) (1). The medical and socioeconomic burden is high and…
  • Abstract Number: 1974 • 2017 ACR/ARHP Annual Meeting

    Efficacy and Safety of Pregabalin for Fibromyalgia in a Population of Chinese Patients: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Trial

    Xiao Zhang1, Huji Xu2, Zhiyi Zhang3, Yang Li4, Lynne Pauer5, Shanmei Liao6, Gaiping Xu7 and Fengchun Zhang8, 1Guangdong General Hospital, Guangdong, China, Guangdong, China, 2Department of Rheumatology and Immunology, Shanghai Changzheng Hospital, Second Military Medical University, Shanghai, China, 3The First Affiliated Hospital of Harbin Medical University, Harbin, China, Harbin, China, 4The Second Affiliated Hospital of Harbin Medical University, Harbin, China, Harbin, China, 5Pfizer, Groton, CT, USA, Groton, CT, 6Pfizer (China) Statistics Department, Global Innovative Pharma Business, Shanghai, China, Shanghai, China, 7Pfizer (China) Clinical Development, Global Innovative Pharma Business, Beijing, China, Beijing, China, 8Peking Union Medical College Hospital, Beijing, China

    Background/Purpose: Global trial data demonstrate the efficacy of pregabalin for the treatment of pain associated with fibromyalgia (FM), but there are currently no approved medical…
  • Abstract Number: 1975 • 2017 ACR/ARHP Annual Meeting

    Association of the 16519 Polymorphism in Patients with Fibromyalgia. Case-Control Study

    Georgina Martínez-Flores1, Marco Ulises Martinez-Martinez2, Victor Mateo Saavedra Alanis3, Tania Adriana Luna-Zúñiga1, Georgina Aguilera Barragán-Pickens1, Dolores Ramos-Bello4, Angel Javier Pedro Martínez1, Eduardo Saul Acevedo-Castañeda5, David Herrera Van Oostdam6, Agustín Abraham Vazquez Castillo3, Mario Alberto Islas Aguilar3 and Carlos Abud-Mendoza7, 1Unidad Regional de Reumatologia y Osteoporosis Hospital Central "Dr. Ignacio Morones Prieto" y Facultad de Medicina de la UASLP, San Luis Potosí, Mexico, 2Unidad de Investigaciones Reumatológicas, Faculty of Medicine, Universidad Autónoma de San Luis Potosí and Hospital Central, San Luis Potosí, Mexico, 3Hospital Central "Dr. Ignacio Morones Prieto". Universidad Autonoma San Luis Potosí, San Luis Potosí, Mexico, 4Reumatología, Unidad Regional de Reumatologia y Osteoporosis Hospital Central "Dr. Ignacio Morones Prieto" y Facultad de Medicina de la UASLP, San Luis Potosi, Mexico, 5Medicina Interna, Unidad Regional de Reumatologia y Osteoporosis Hospital Central "Dr. Ignacio Morones Prieto" y Facultad de Medicina de la UASLP, San Luis Potosí, Mexico, 6Unidad de Investigaciones Reumatológicas, Hospital Central & Facultad de Medicina, Universidad Autónoma de San Luis Potosí, San Luis Potosí, Mexico, 7Unidad de Investigaciones Reumatológicas y Osteoporosis, Faculty of Medicine, Universidad Autónoma de San Luis Potosí and Hospital Central, San Luis Potosí, Mexico

    -      Background/Purpose: More than 20% of the general population suffer from functional syndromes. It has been reported that the mitochondrial polymorphism at position 16519 is…
  • Abstract Number: 1976 • 2017 ACR/ARHP Annual Meeting

    High and Low Widespread Pain Index Fibromyalgia Patient Groups, Same, or Different?

    Sahar Kaouk1, Yaseen Kinanah2, Nilamba Jhala3, Deb Bork4, Sarah Rispinto5, Sara Davin5, William Wilke4 and Carmen E. Gota4,6, 1John Carroll University, University Heights, OH, 2Internal Medicine, Cleveland Clinic Foundation, Cleveland, OH, 3Internal Medicine, Cleveland Clinic, Cleveland, OH, 4Orthopedic and Rheumatologic Institute, Cleveland Clinic, Cleveland, OH, 5Neurologic Institute, Cleveland Clinic, Cleveland, OH, 6The Cleveland Clinic Rheum, The Cleveland Clinic Desk A50, Cleveland, OH

    Background/Purpose: The ACR 2010 preliminary criteria for fibromyalgia (FM) classifies patients in high WPI group, widespread pain index (WPI) ≥7, symptom severity scale (SS) ≥5,…
  • Abstract Number: 1977 • 2017 ACR/ARHP Annual Meeting

    Elevated Levels of Eotaxin-2 in Serum of Fibromyalgia Patients

    Victoria Furer1, Eyal Hazan2, Adi Mor3, Michal Segal3, Avi Katav3, Valerie Aloush4, Ori Elkayam4, Jacob George3,5 and Jacob N. Ablin6,7, 1Rheumatology, Tel Aviv Sourasky Medical Center and the Sackler Faculty of Medicine, Tel Aviv University, Tel-Aviv, Israel, 2Internal Medicine D, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel, 3ChemomAb Ltd. Israel, Tel Aviv, Israel, 4Rheumatology, Tel Aviv Sourasky Medical Center and the Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel, 5Heart Institute, Kaplan Medical Center, Rehovot, Israel, 6Internal Medicine H, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel, 7Rheumatology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel

    Background/Purpose: Fibromyalgia is a widespread chronic pain syndrome (FMS) the pathogenesis of which remains incompletely understood. FMS patients demonstrate an altered profile of chemokines relative…
  • Abstract Number: 1978 • 2017 ACR/ARHP Annual Meeting

    Employment Status in Fibromyalgia: Comparison of  Employed and  Unemployed Patients and Predictors of Unemployed Status

    Yaseen Kinanah1, Nilamba Jhala2, Sahar Kaouk3, Deb Bork4, Sara Davin5, Sarah Rispinto5, William Wilke4 and Carmen E. Gota4, 1Internal Medicine, Cleveland Clinic Foundation, Cleveland, OH, 2Internal Medicine, Cleveland Clinic, Cleveland, OH, 3John Carroll University, University Heights, OH, 4Orthopedic and Rheumatologic Institute, Cleveland Clinic, Cleveland, OH, 5Neurologic Institute, Cleveland Clinic, Cleveland, OH

    Background/Purpose: Disabled status in fibromyalgia (FM) was found to be associated with lower education, higher FM symptom burden, and lower functional status. Less is known…
  • Abstract Number: 1979 • 2017 ACR/ARHP Annual Meeting

    Relationship between Religiosity /Spirituality and Physical and Mental Outcomes in Fibromyalgia Patients

    Valerie Aloush1, Eyal Hazan2, Ran Shorer3, Victoria Furer4, Ori Elkayam1 and Jacob N. Ablin5, 1Rheumatology, Tel Aviv Sourasky Medical Center and the Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel, 2Internal Medicine D, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel, 3Rheumatology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel, 4Rheumatology, Tel Aviv Sourasky Medical Center and the Sackler Faculty of Medicine, Tel Aviv University, Tel-Aviv, Israel, 5Internal Medicine H, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel

    Background/Purpose: Similar to other chronic disorders, Fibromyalgia syndrome (FMS) poses a major challenge for patients coping capacities and extracts a far-reaching cost on functioning and…
  • Abstract Number: 1980 • 2017 ACR/ARHP Annual Meeting

    Impact of Whole-Body Cryotherapy on Gene Expression of Peripheral Blood Cells in Patients with Fibromyalgia and Association with Patient-Reported Outcomes

    Susanne Drynda1, Oliver Mika2 and Joern Kekow3, 1University of Magdeburg, Clinic of Rheumatology, Vogelsang-Gommern, Germany, 2University of Magdeburg, Clinic of Rheumatology, Gommern, Germany, 3University of Magdeburg, Clinic of Rheumatology, Magdeburg, Germany

    Background/Purpose: Whole-body cryotherapy (WBCT) has been demonstrated in several studies as being effective in the reduction of inflammatory symptoms and in providing pain relief. It…
  • Abstract Number: 1981 • 2017 ACR/ARHP Annual Meeting

    The Etiology of Fibromyalgia May be Related to Increased Muscle Pressure

    Robert S. Katz1, Jessica L. Polyak2, Alexandra Katz Small3, Ben J Small4 and Frank Leavitt1, 1Rush University Medical Center, Chicago, IL, 2Rheumatology Associates S.C., Chicago, IL, 3University of Illinois College of Medicine, Chicago, IL, 4Rheumatology, University of Illinois at Chicago Medical School, Chicago, IL

    The Etiology of Fibromyalgia May be Related to Increased Muscle PressureBackground/Purpose:  The muscles are tender in fibromyalgia syndrome (FMS) patients, and the location of pain…
  • Abstract Number: 1982 • 2017 ACR/ARHP Annual Meeting

    Leptin, a Hypothalamic Signaling Hormone, Is Elevated in Fibromyalgia Patients

    Robert S. Katz, Rush University Medical Center, Chicago, IL

    Background/Purpose: Leptin, a 16 kDa protein, acts on receptors in brain neurons, especially in the hypothalamus. It could affect the hypothalamic-pituitary axis and be involved…
  • Abstract Number: 1983 • 2017 ACR/ARHP Annual Meeting

    The Types of Stress That Appear to Aggravate the Symptoms of Fibromyalgia

    Robert S. Katz, Rush University Medical Center, Chicago, IL

    Background/Purpose: The types of stresses evaluated include financial stress (i.e., decreased income, unexpected expenses or out-goings); employment stress (i.e. job promotion, relocation, increased workload or…
  • Abstract Number: 1984 • 2017 ACR/ARHP Annual Meeting

    The Cervical Spine in Fibromyalgia Patients:  Loss of Lordotic Curve Is Characteristic of Fibromyalgia and Can Assist in the Diagnosis

    Robert S. Katz1, Alexandra Katz Small2, Ben J Small3 and Anthony Farkasch4, 1Rush University Medical Center, Chicago, IL, 2University of Illinois College of Medicine, Chicago, IL, 3Rheumatology, University of Illinois at Chicago Medical School, Chicago, IL, 4Rheumatology Associates S.C., Chicago, IL

    Background/Purpose:  Patients with fibromyalgia have widespread pain. We have found that a lateral view of a cervical spine radiograph frequently identifies a loss of the…
  • Abstract Number: 1985 • 2017 ACR/ARHP Annual Meeting

    Cervical Spine Radiographs in Fibromyalgia Patients Show Reduced Cobb Angle and Suggest the Presence of Increased Muscle Pressure As a Cause of the Illness

    Robert S. Katz1, Ben J Small2, Alexandra Katz Small3 and Anthony Farkasch4, 1Rush University Medical Center, Chicago, IL, 2Rheumatology, University of Illinois at Chicago Medical School, Chicago, IL, 3University of Illinois College of Medicine, Chicago, IL, 4Rheumatology Associates S.C., Chicago, IL

    Background/Purpose:   Fibromyalgia patients are reported to have a straight neck on lateral x-ray views of the cervical spine. We measured the Cobb angle in…
  • Abstract Number: 1986 • 2017 ACR/ARHP Annual Meeting

    Using the BILAG to Assess the Activity of Lupus in Patients with Fibromyalgia

    Robert S. Katz1, Jessica L. Polyak2 and Frank Leavitt1, 1Rush University Medical Center, Chicago, IL, 2Rheumatology Associates S.C., Chicago, IL

    Background/Purpose:  The BILAG is often used to assess the efficacy of lupus treatments, and is a commonly used tool in lupus drug trials. But the…
  • « Previous Page
  • 1
  • …
  • 1335
  • 1336
  • 1337
  • 1338
  • 1339
  • …
  • 2425
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology